Suresh Muthukumaraswamy

Suresh is  a Professor in psychopharmacology at The University of Auckland. Suresh’s main research interests are in understanding how therapies alter brain function, mood and behaviour and has written extensively on clinical trial design in psychedelic science. Suresh began studying the psychedelics as postdoctoral fellow in 2011 with studies of psilocybin then later ketamine and LSD. He has received several Health Research Council of New Zealand research grants to support this work including grants to investigate the effects of microdoses of LSD and the antidepressant effects of ketamine. Suresh has published >140 papers, with his work receiving >10000 citations.